Skip to main content

Treace Medical Concepts, Inc.

TMCI
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001630627

In the last 90 days, Treace Medical Concepts, Inc. insiders filed 1 open-market purchase and 0 sales; 116 institutions reported holding it in 13F filings for Q2 2026, worth $126.8M in total; no superinvestor holds it.

Holders of 5% or more of TMCI

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Treace Medical Concepts, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of TMCI
HolderLatest formStakeChangeFirst filedLatest filingFiling
Armistice Capital, LLC13G/A9.99%6.32M shares+0.07 ppfrom 9.92%Feb 14, 20253 filingsNov 14, 2025SEC
Armistice Capital, LLC13G/A9.91%6.26M shares–Aug 15, 20251 filingAug 15, 2025SEC
Gagnon Securities LLC13G6.30%3.98M sharesNewMay 15, 20251 filingMay 15, 2025SEC
William Blair Investment Management, LLC13G5.80%3.66M sharesNewNov 12, 20251 filingNov 12, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

7 Schedule 13D and 13G filings on Treace Medical Concepts, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on TMCI
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 14, 20256:27 PM ETArmistice Capital, LLCand 1 other13G/A9.99%6.32M shares+0.07 ppfrom 9.92%Sep 30, 2025SEC
Nov 12, 20255:54 PM ETWilliam Blair Investment Management, LLC13G5.80%3.66M sharesNewSep 30, 2025SEC
Aug 15, 202512:29 PM ETArmistice Capital, LLCand 1 other13G/A9.91%6.26M shares–Jun 30, 2025SEC
May 15, 20254:30 PM ETGagnon Securities LLCand 2 others13G6.30%3.98M sharesNewMay 9, 2025SEC
May 15, 20253:19 PM ETArmistice Capital, LLCand 1 other13G/A9.92%6.21M shares−0.05 ppfrom 9.97%Mar 31, 2025SEC
Feb 14, 20255:21 PM ETArmistice Capital, LLCand 1 other13G/A9.97%6.21M shares–Dec 31, 2024SEC
Feb 3, 20254:38 PM ETMorgan Stanley13G/A3.40%2.09M shares–Below 5%Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Treace Medical Concepts, Inc. shares.

No Form 144 notices for Treace Medical Concepts, Inc. are on file.